Skip to main contentAll experts

DrElias Sayour

AST DEAN & PROF

MD-NEUROLOGICAL SURGERY

Orcid identifier0000-0002-5309-3197 (opens in a new tab)⁠
  • AST DEAN & PROF
    MD-NEUROLOGICAL SURGERY

GRANTS

  • GRANT
    Florida’s Catalyst for Childhood Cancer Cures: A JHACH-CBDI Pediatric Cancer Research Initiative
    Florida Department of Health21 Jul 2026 - 30 Jun 2026
    Expired
  • GRANT
    RNA Loaded Nanoparticle Aggregates for Glioblastoma
    National Institute of Health Nci30 Jun 2026 - 30 Jun 2031
    Active
  • GRANT
    Modulation of Therapeutic Response in Lung Cancer by Tumor Suppressor LKB1
    National Institute of Health Nci19 Jun 2026 - 30 Jun 2031
    Active
  • GRANT
    Overcoming the blood-brain barrier with nanoparticle vaccines against gliomas
    National Institute of Health Nci8 Jun 2026 - 31 Jan 2028
    Active
  • GRANT
    Florida’s Catalyst for Childhood Cancer Cures: A JHACH-CBDI Pediatric Cancer Research Initiative: Catalyst Pillar 3a RNA Center
    Florida Department of Health14 May 2026 - 30 Jun 2026
    Expired
  • GRANT
    A Phase 2 De-escalation Study of Dabrafenib and Trametinib for Patients with BRAF V600 Mutant Low-Grade Gliomas
    Rising Tide Foundation for Clinical Cancer Research29 Apr 2026 - 31 Aug 2028
    Active
  • GRANT
    Mechanisms of RNA Immunotherapy for type 1 diabetes prevention
    Pediatric Endocrine Society3 Apr 2026 - 30 Jun 2027
    Active
  • GRANT
    Next-generation mRNA vaccine for glioblastoma
    Ioncologi31 Mar 2026 - 31 Mar 2027
    Active
  • GRANT
    SDHB Pheo para-Tumor Vaccine Development for SDHB
    Sdhb Pheo Para Coalition19 Mar 2026 - 30 Apr 2029
    Active
  • GRANT
    Unlocking CAR T cells Activity Against Metastatic Osteosarcoma Using Systemic RNA Vaccination
    Hyundai Hope On Wheels11 Dec 2025 - 31 Dec 2026
    Active
  • GRANT
    NOVEL CORRELATIVE ASSESSMENTS OF PERFORMANCE OF QUAD-TARGETING CAR T CELLS FOR CHILDREN AND YOUNG ADULTS WITH DIPG OR DMG
    Dipg Dmg Research Funding Alliance4 Dec 2025 - 30 Apr 2026
    Expired
  • GRANT
    Enhancing Immunotherapy Efficacy in NSCLC through Tumor Antigen-Targeted RNA Nanoparticles
    Florida Department of Health Biomed Research Pgm/J&E King6 Nov 2025 - 30 Sep 2028
    Active
  • GRANT
    A Single Arm Pilot of Neoadjuvant Checkpoint Inhibition followed by Adjuvant Checkpoint Inhibition in Children and Young Adults with Recurrent or Progressive High Grade Glioma (HGG)
    Glioblastoma Research Organization23 Oct 2025 - 31 Jul 2026
    Expired
  • GRANT
    Overcoming metastatic spread of osteosarcoma with RNA loaded nanoparticles
    National Institute of Health Nci4 Sep 2025 - 31 Aug 2027
    Active
  • GRANT
    Developing a Functional Predictive Biomarker for an mRNA-LP Cancer Vaccine Clinical Trial Using Each Patient’s Own Living Tumor Tissue
    National Pediatric Cancer Foundation1 Sep 2025 - 30 Jun 2027
    Active
  • GRANT
    Combining Epigenetic Therapy and Immunotherapy to Target Group 4 Medulloblastoma
    Childrens Research Institute25 Aug 2025 - 30 Dec 2026
    Active
  • GRANT
    To develop novel lipid nanoparticle-based therapeutics to target H2.0-like homeobox transcription factor (HLX) to treat Group 3 medulloblastoma in children
    Florida Department of Health Live Like Bella1 Aug 2025 - 31 Jul 2028
    Active
  • GRANT
    Multilamellar RNA aggregates targeting diffuse midline glioma, including diffuse intrinsic pontine glioma
    The Cure Starts Now25 Jul 2025 - 30 Apr 2026
    Expired
  • GRANT
    The Florida Summer Training in Research and Oncology for the Next Generation of Researchers (STRONGER) Program
    National Institute of Health Nci24 Jun 2025 - 31 May 2030
    Active
  • GRANT
    The Sunshine Project: Development of RNA Loaded Nanoparticles for Children with Refractory Solid Tumors
    National Pediatric Cancer Foundation2 May 2025 - 30 Jun 2026
    Expired
  • GRANT
    ReSubmission R01 Role of bacterial-derived small molecules in immunotherapy
    National Institute of Health Nci22 Apr 2025 - 30 Apr 2030
    Active
  • GRANT
    HLX drives the G3 MB growth and is a potential candidate drug target to treat G3 MBs
    Johns Hopkins All Childrens Hospital15 Apr 2025 - 30 Jun 2026
    Expired
  • GRANT
    Nivolumab and DAY101 for the treatment of newly diagnosed or recurrent craniopharyngioma in children and young adults
    Childrens Hospital Philadelphia4 Oct 2024 - 3 Oct 2029
    Active
  • GRANT
    Task Order Number: 15349sc PNOC COMP
    Pacific Pediatric Neuro-Oncology Consort12 Sep 2024 - 13 Sep 2024
    Closed
  • GRANT
    Task Order Number: 15349sc PNOC COMP#
    Pacific Pediatric Neuro-Oncology Consort12 Sep 2024 - 11 Sep 2029
    Active